Bullous pemphigoid induced by <scp>IgG</scp> targeting type <scp>XVII</scp> collagen <scp>non‐NC16A</scp> / <scp>NC15A</scp> extracellular domains is driven by Fc gamma receptor‐ and complement‐mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockadeManuela Pigors, Enno Schmidt, Peter Verheesen et al.|The Journal of Pathology|2023Cited by 21
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Ralf J. Ludwig, Mayumi Kamaguchi et al.|Frontiers in Immunology|2022Cited by 9
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseasesSaeedeh Ghorbanalipoor, Ralf J. Ludwig, Kathrin Kalies et al.|Frontiers in Immunology|2022Cited by 7
Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous PemphigoidStanislav Khil’chenko, Ralf J. Ludwig|Frontiers in Medicine|2020Cited by 5